Skip to content

Evaluating Nine-Year Sustainability After Implementing Evidence-Based Practices to Prevent Urinary Tract Infections and Overfilling of the Bladder in Patients With Hip Fracture

Nine-Year Sustainability After Implementing Measures to Prevent Catheter- Associated Urinary Tract Infections and Bladder Distension in Patients With Hip Fracture

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06893562
Enrollment
750
Registered
2025-03-25
Start date
2025-05-05
Completion date
2025-10-30
Last updated
2026-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adherence, Documentation Skill, Hip Fracture, Sustainability of Innovations, Urinary Catheters, Urinary Retention, UTI - Urinary Tract Infection

Keywords

Sustainability of Innovations, Hip fracture, Urinary Retention, Catheter Associated Urinary Tract Infection

Brief summary

This study focuses on evaluating the long-term sustainability of a urinary catheter care bundle designed to prevent urinary tract infections and bladder distension in patients undergoing surgery for hip fractures. The intervention, which included two key innovations-a urinary catheter certificate and a nurse-driven urinary catheter protocol, was implemented between 2015 and 2020 and successfully reduced urinary tract infections and bladder distension, previously published. However, due to the pandemic, the initiative was paused and had to be reintroduced in 2022. Now, the study aims to assess the effectiveness of these preventive measures 9 years after their initial implementation. The research will analyze changes in the incidence of urinary tract infections, bladder distension, catheterisation methods, and documentation practices in patients aged 65 and older. The findings will help inform healthcare policies and may have broader implications for preventing adverse events in other surgical patient groups

Interventions

BEHAVIORALSafe Hands and Safe Bladder intervention

Evaluating changes in urinary tract infections and bladder distension nine-year after implementing preventive measures

Sponsors

Sahlgrenska University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

-Hip fracture surgery at the study site, age 65 years and older and cared for in the ortho-geriatric wards.

Exclusion criteria

-No catheterisation during hospital stay

Design outcomes

Primary

MeasureTime frameDescription
Describe changes in the incidence of in-hospital urinary catheter-associated infections; Year 9 will be compared with previously published data from Years 1-5For one yearDefinition: Urinary tract infection with onset on day 3 after admission with prior urinary catheterisation. A physician prescribed antimicrobial agents for a urinary tract infection during the hospital stay. Data will be collected from patients' medical records. Logistic regression analysis will be performed

Secondary

MeasureTime frameDescription
Changes in the incidence of in-hospital acquired bladder distension will be compared; Year 9 will be compared to previously published data from Years 1-5.For one year.Definition: Bladder distension is defined according to the national marker for point prevalence measurement when assessing adverse events. Bladderscan volume from patients' medical records.
Changes in urine volume of 500ml and more during hospital stay. Year nine will be compared yera 1-5, previous published dataFor one yearBladderscan volume from patients' medical records.
Changes in catheterization methods during the hospital stay will be compared, with data from Year 9 compared to previously published data from Years 1-5For one yearData will be collected from patients' medical records.
Changes in urinary catheter-related documentation in Year 9 will be compared to previously published data from Years 1-5.For one yearCatheter-related documentation will be collected from patients' medical records.

Countries

Sweden

Contacts

PRINCIPAL_INVESTIGATORAnnette Erichsen, Associate Professor

Gothenburg University, Sahlgrenska University Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026